North Carolina court upholds denial of eugenics compensation
By Gary D. Robertson,
Associated Press
| 06. 06. 2017
RALEIGH, N.C. (AP) — Some surviving relatives of people involuntarily sterilized by the state of North Carolina decades ago can't get financial compensation from the state, an appeals court affirmed Tuesday.
The state court said the victims in those cases died before a legal cutoff date that determines who's qualified to receive the money.
A Court of Appeals panel unanimously upheld decisions by a state commission to deny compensation to three estates. The North Carolina Industrial Commission oversees payments from $10 million set aside by the General Assembly in 2013." A Court of Appeals panel unanimously upheld decisions by a state commission to deny compensation to three estates. The North Carolina Industrial Commission oversees payments from $10 million set aside by the General Assembly in 2013.
About 7,600 people deemed "feeble-minded" or otherwise undesirable were sterilized between 1929 and 1974. The law said victims still alive on June 30, 2013 could qualify to receive the money. Payments of $35,000 each have been made so far to about 200 people. The estates of those who were alive on that date but...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...
